Probiotic Use for Recovery Enhancement From Long COVID-19
NCT06643299
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
180
Enrollment
OTHER
Sponsor class
Conditions
Post-Acute COVID-19 Syndrome
Interventions
DRUG:
Probiotic Agent
OTHER:
Placebo
Sponsor
Rush University Medical Center